Determination of stavudine, a new antiretroviral agent, in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection

David M. Burger(Radboud University Nijmegen), Jos H. Beijnen(The Netherlands Cancer Institute), R. van Gijn(Slotervaartziekenhuis), Olaf van Tellingen(Dutch Cancer Society), Hilde Rosing(The Netherlands Cancer Institute), P. L. Meenhorst(Leiden University Medical Center)
Journal of Chromatography B Biomedical Sciences and Applications
December 1, 1992
10.1016/0378-4347(92)80581-a
Cited by 36

Related Papers

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.
|PubMed|2002|688